Bristol-Myers Squibb
BMY
#189
Rank
A$159.86 B
Marketcap
A$78.53
Share price
0.38%
Change (1 day)
-12.37%
Change (1 year)

Bristol-Myers Squibb (BMY) - Cash on Hand

Cash on Hand as of September 2025 : A$24.84 Billion

According to Bristol-Myers Squibb's latest financial reports the company has A$24.84 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Bristol-Myers Squibb - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$17.45 B-3.14%
2023-12-31A$18.02 B32.56%
2022-12-31A$13.59 B-42.76%
2021-12-31A$23.75 B11.03%
2020-12-31A$21.39 B-2.69%
2019-12-31A$21.98 B76.83%
2018-12-31A$12.43 B42.5%
2017-12-31A$8.72 B-0.95%
2016-12-31A$8.80 B50.29%
2015-12-31A$5.86 B-35.48%
2014-12-31A$9.08 B79.08%
2013-12-31A$5.07 B86.35%
2012-12-31A$2.72 B-68.04%
2011-12-31A$8.51 B18.5%
2010-12-31A$7.18 B-24.16%
2009-12-31A$9.47 B-19.1%
2008-12-31A$11.71 B360.32%
2007-12-31A$2.54 B-50.01%
2006-12-31A$5.09 B-35.77%
2005-12-31A$7.92 B-17.94%
2004-12-31A$9.65 B29.07%
2003-12-31A$7.48 B5.69%
2002-12-31A$7.08 B-36.09%
2001-12-31A$11.07 B82.99%
2000-12-31A$6.05 B34.54%
1999-12-31A$4.49 B22.79%
1998-12-31A$3.66 B63.99%
1997-12-31A$2.23 B5.61%
1996-12-31A$2.11 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
A$22.56 B-9.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$27.42 B 10.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$14.92 B-39.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$14.68 B-40.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
A$15.73 B-36.66%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
A$12.32 B-50.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
A$27.95 B 12.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$8.53 B-65.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.22 B-42.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$5.96 B-76.00%๐Ÿ‡บ๐Ÿ‡ธ USA